Journals / Literatür Eczacılık Bilimleri Dergisi / 2019 / Cilt: 8 - Sayı: 2

Overview on the Orally Disintegrating Tablet Formulations

Ağızda Hızlı Çözünen Tablet Formülasyonlarına Genel Bakış

Pages
97–107
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After the ODTs are prepared, the wetting time and the amount of moisture of the tablets are tested, as well as the quality parameters performed on conventional tablets like weight deviation, friability, dissolution and assay.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Oral drug administration is a widely used administration route.
📊
Key Findings & Data:Nowadays, new solid dosage forms are being studied to ensure compliance with medication and to facilitate drug administration especially for patients suffering from pediatric, geriatric, and swallowing difficulties for any reason.
💡
Conclusion & Impact:After the ODTs are prepared, the wetting time and the amount of moisture of the tablets are tested, as well as the quality parameters performed on conventional tablets like weight deviation, friability, dissolution and assay.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Oral drug administration is a widely used administration route. Nowadays, new solid dosage forms are being studied to ensure compliance with medication and to facilitate drug administration especially for patients suffering from pediatric, geriatric, and swallowing difficulties for any reason. Oral disintegrating tablets (ODTs) are tablet forms which, when placed on the tongue, break up with the help of saliva and then join the bloodstream of the active substance from the oropharyngeal space without the need for water. Besides the advantages of conventional solid dosage forms, ODTs have some advantages, such as the ability of more drug to participate in systemic circulation, higher bioavailability and therapeutic efficacy. In addition to using conventional methods such as sublimation and lyophilization to formulate ODTs, patented modified methods have also been developed. After the ODTs are prepared, the wetting time and the amount of moisture of the tablets are tested, as well as the quality parameters performed on conventional tablets like weight deviation, friability, dissolution and assay.

Özet

Oral yolla ilaç kullanımı yaygın olarak kullanılan bir ilaç uygulama yoludur. Günümüzde, özellikle pediatrik, geriatrik ve herhangi bir nedenle yutma güçlüğü çeken hastalar için tedaviye uyumun sağlanması ve ilaç uygulamasının kolaylaştırılması amacıyla yeni dozaj formları üzerine çalışılmaktadır. Ağızda dağılan tabletler (ADT’ler) dil üzerine yerleştirildiğinde, tükürük yardımı ile parçalanan ve daha sonra suya ihtiyaç duymadan oromukozal boşluktan etken maddenin kan dolaşımına katıldığı tablet şekilleridir. Bu tablet formları, geleneksel katı dozaj şekillerinin sahip olduğu üstünlüklerin yanı sıra; hepatik metabolizmayı elimine ederek, daha fazla ilacın sistemik dolaşıma katılması ve bunun sonucunda da daha yüksek biyoyararlanım ve terapötik etkinliğe ulaşılması gibi diğer bazı avantajlara da sahiptirler. ADT'leri formüle etmek için, süblimasyon, liyofilizasyon vb. gibi klasik yöntemler kullanılmakla birlikte, patentli modifiye yöntemler de geliştirilmiştir. ADT’lerde, ağırlık sapması, ufalanma-aşınma, dağılma, çözünme ve etken madde miktar tayini gibi klasik tabletlerde yapılan kontrollerin yanı sıra tabletlerin ıslanma zamanı ve nem çekme miktarları da belirlenmektedir.

🔖

Cite This Article

ÖZYILMAZ, E., ÇOMOĞLU, T. (2019). Overview on the Orally Disintegrating Tablet Formulations. Literatür Eczacılık Bilimleri Dergisi, Cilt: 8 - Sayı: 2, 97–107. https://ajindex.com/articles/274585

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Comoglu T. Formulation and evaluation of carbamazepine fast disintegrating tablets. Pharm Ind. 2010;72(1):150-8
  2. Gulsun T, Cayli YA, Izat n, Cetin M, Oner L, Sahin S. Development and evaluation of terbutaline sulfate orally disintegrating tablets by direct compression and freeze drying methods. j Drug Deliv Sci Tec. 2018;46(1):251-8. [Crossref] 3. Husseiny RA, Abu Lila AS, Abdallah MH, Elghamry HA. Fast disintegrating tablet of valsartan for the treatment of pediatric hypertension: in vitro and in vivo evaluation. j Drug Deliv Sci Tec. 2018;43(1):194-200. [Crossref] 4. Sheshala R, Khan n, Chitneni M, Darwis Y. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants. Arch Pharm Res. 2011;34(1):1945-56. [Crossref] [PubMed] 5. bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm bull (Tokyo). 1996;44(1):2121-7. [Crossref] 6. Chowdary KPR, Shankar KR, Suchitra b. Recent research on orodispersible tablets-a review. Int Res j Pharm. 2014;4(1):64-73
  3. Hu X, Li Y, Zhang E, Wang X, Xing M, Wang Q, et al. Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochloride. AAPS Pharm Sci Tech. 2013;14(1):29-37. [Crossref] [PubMed] [PMC] 8. Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S. Further improvement of orally disintegrating tablets using micronized ethylcellulose. Int j Pharm. 2012;423(2):351- 9. [Crossref] [PubMed] 9. Comoglu T, Dogan A, Comoglu S, basci n. Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients. Drug Dev Ind Pharm. 2011;37(1):260-7. [Crossref] [PubMed] 10. Hannan PA, Khan jA, Khan A, Safiullah S. Oral dispersible system: a new approach in drug delivery system. Indian j Pharm Sci. 2016;78(1):2-7. [Crossref] [PubMed] [PMC] 11. Thulluru A, Kumar KM, Chandana Priya E, Mounika R, Munichandra K. Formulation and evaluation of tadalafil oral disintegrating tablets with enhanced dissolution rate by complexation. Int j Res Development Pharmacy. 2017;6(1):2631-40. [Crossref] 12. Seager H. Drug-delivery products and the Zydis fast-dissolving dosage form. j Pharm Pharmacol. 1998;50(1):375-82. [Crossref] [PubMed] 13. bircan Y, Çomoǧlu T. Formulation technologies of orally fast disintegrating tablets. Marmara Pharm j. 2012;16(1):77-81. [Crossref] 14.